Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
((????)) Flash Back - Dance Music das Baladas...
Dance Moms: JOJO IS BACK! at the ALDC (Season...
India is becoming less attractive to foreign...
Indian households going back to safe bank...
LSE's $27 billion deal rehabilitates Refinitiv...
Britain's LSE delivers 'defining' $27 billion...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version